Orgenesis Revenue Per Share from 2010 to 2025
| ORGSDelisted Stock | USD 1.22 0.31 20.26% |
Check Orgenesis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Orgenesis financial statements analysis is a perfect complement when working with Orgenesis Valuation or Volatility modules.
Orgenesis |
About Orgenesis Financial Statements
Orgenesis shareholders use historical fundamental indicators, such as Revenue Per Share, to determine how well the company is positioned to perform in the future. Although Orgenesis investors may analyze each financial statement separately, they are all interrelated. The changes in Orgenesis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Orgenesis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Orgenesis OTC Stock
If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |